ANI PHARMACEUTICALS INC (ANIP) › Total LiabilitiesANI PHARMACEUTICALS INC (ANIP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $25.62M2011: $24.56M2012: $10.59M2013: $3.54M2014: $119.77M2015: $125.18M2016: $153.22M2017: $237.38M2018: $233.34M2019: $244.00M2020: $265.49M2021: $412.86M2022: $421.55M2023: $446.82M2024: $855.94M2025: $899.65M$899.65M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$899.65M+5.1%2024$855.94M+91.6%2023$446.82M+6.0%2022$421.55M+2.1%2021$412.86M+55.5%2020$265.49M+8.8%2019$244.00M+4.6%2018$233.34M-1.7%2017$237.38M+54.9%2016$153.22M+22.4%2015$125.18M+4.5%2014$119.77M+3285.3%2013$3.54M-66.6%2012$10.59M-56.9%2011$24.56M-4.1%2010$25.62M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share